Stocklytics Platform

Performance History

Chart placeholder
Key Stats
Open$42.56
Prev. Close$41.96
EPS-3.98
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$4.16B
PE Ratio-
LOWHIGH
Day Range40.92
42.56
52 Week Range6.40
42.56
Ratios
P/B Ratio24.40
Revenue-
Operating M. %0.00%
Earnings$0.00
Earnings Growth %-40.36%
EBITDA Margin %-
ROE %-71.50%
EPS-3.98

Score Breakdown

no data available for score breakdown

There's no data available for score breakdown

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$948.40
Perf. (24h)
arrow_drop_up1.52%$14.26
Market Cap$841.10B
Price$511.53
Perf. (24h)
arrow_drop_up1.42%$7.17
Market Cap$464.20B
Price$149.88
Perf. (24h)
arrow_drop_up0.12%$0.18
Market Cap$360.27B
Price$127.76
Perf. (24h)
arrow_drop_down0.93%-$1.21
Market Cap$326.65B

About Dyne Therapeutics (DYN)

Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Joshua T. Brumm
Headquarters
Waltham
Employees
134
Exchange
NASDAQ
add Dyne Therapeutics  to watchlist

Keep an eye on Dyne Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Dyne Therapeutics 's (DYN) price per share?

The current price per share for Dyne Therapeutics (DYN) is $41.54. The stock has seen a price change of -$0.42 recently, indicating a -1% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Dyne Therapeutics (DYN)?

For Dyne Therapeutics (DYN), the 52-week high is $42.56, which is 2.46% from the current price. The 52-week low is $6.4, the current price is 549.06% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Dyne Therapeutics (DYN) a growth stock?

Dyne Therapeutics (DYN) has shown an average price growth of 0.41% over the past three years. It has received a score of 88 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Dyne Therapeutics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Dyne Therapeutics (DYN) stock price performance year to date (YTD)?

As of the latest data, Dyne Therapeutics (DYN) has a year-to-date price change of 218.07%. Over the past month, the stock has experienced a price change of 23.3%. Over the last three months, the change has been 63.29%. Over the past six months, the figure is 148.3%.

help
Is Dyne Therapeutics (DYN) a profitable company?

Dyne Therapeutics (DYN) has a net income of -$235.94M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$242.16M. Furthermore, the EBITDA is -$264.21M.

help
What is the market capitalization of Dyne Therapeutics (DYN)?

Dyne Therapeutics (DYN) has a market capitalization of $4.17B. The average daily trading volume is 1.34M, indicating the stock's liquidity and investor engagement.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level

Stocklytics Platform

© 2024 Stocklytics, Inc. All rights reserved.

Stocklytics isn't a brokerage or dealer; it's supported by an affiliated investment adviser for an exchange traded fund. However, this adviser doesn't offer guidance to individual investors. None of the information on Stocklytics suggests buying or selling securities. The site and its newsletters aren't intended as investment advice. It's important to note that past performance isn't indicative of future results. Stocklytics doesn't guarantee the completeness or accuracy of its information. Also, the listed entities aren't affiliated with Stocklytics, LLC. Stock quotes come from InterActive Data, and Morningstar provides daily updated fundamental company data.

Stocklytics Discord public channelStocklytics X Social Media